AVIEW LCS vs CARTO 3 EP Navigation System Software V8.0 (FG-5400-00
AI Verdict
Choose AVIEW LCS if…
Choose AVIEW LCS if your institution requires a comprehensive, AI-powered solution for integrated lung cancer screening, COPD assessment, and coronary artery calcification scoring from a single low-dose CT scan. This tool is ideal for radiology departments focused on enhancing diagnostic accuracy for pulmonary nodules and efficiently managing patient follow-up with automated comparison capabilities.
View AVIEW LCS →Choose CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 if…
Choose CARTO™ 3 EP Navigation System Software V8.0 if you are an electrophysiologist seeking an advanced, AI-powered 3D cardiac mapping and navigation system for diagnosing and treating complex heart rhythm disorders. This system is specifically designed to provide highly accurate catheter visualization and rapid, high-resolution anatomical maps to optimize ablation procedures for conditions like AFib and VT.
View CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 |
|---|---|---|
| Pricing | Subscription or one-off payment | Unknown |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | On-premise (system with specialized hardware) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AVIEW LCSAVIEW LCS demonstrates superior usability by significantly streamlining high-volume diagnostic workflows, with reported reductions of up to 86.7% in radiologist workload and 60-89% in interpretation time and case throughput. Its integration with existing PACS/RIS and automated report generation facilitate a more efficient and less manual diagnostic process for multiple diseases.
Clinical Value
AVIEW LCSAVIEW LCS offers broad clinical value by providing highly accurate, multi-disease detection and quantification (lung cancer, COPD, CAC, osteoporosis) from a single low-dose CT scan, outperforming human radiologists in certain nodule identification aspects and significantly reducing false negatives in cancer detection. This comprehensive approach enables earlier diagnosis and improved risk stratification for several prevalent and serious conditions.
Pricing & Value
AVIEW LCSWhile both tools require direct contact for pricing, AVIEW LCS provides more concrete, quantifiable metrics on its economic benefits, reporting a 79.5% ROI and a 60-71.2% reduction in radiologist reading time. Its multi-disease screening capability from a single scan also suggests a higher value per scan by optimizing resource utilization in diagnostic workflows.
Enterprise Readiness
AVIEW LCSAVIEW LCS offers greater flexibility with cloud, hybrid, local, and virtualized deployment options, alongside robust integration with PACS/RIS and third-party platforms. [cite: 8 in Enterprise Readiness search] Its proven track record of processing over 2.5 million cases across 19 countries demonstrates strong scalability and adaptability for diverse enterprise IT environments. [cite: 7 in Enterprise Readiness search]
Innovation
CARTO 3 EP Navigation System Software V8.0 (FG-5400-00CARTOu2122 3 EP demonstrates pioneering innovation with its FDA-cleared AI algorithm for automated 3D left atrial anatomy creation using intracardiac ultrasound, a first in its class for interventional cardiology. [cite: 7 in Pricing & Value search, 15 in Pricing & Value search] Its unique current- and magnetic-based technology for distortion-free catheter visualization further highlights its advanced technological leadership in complex electrophysiology procedures. [cite: 2 in Enterprise Readiness search]
Support & Docs
CARTO 3 EP Navigation System Software V8.0 (FG-5400-00CARTOu2122 3 EP provides a more specialized and immediate support structure, explicitly offering a 'team of clinical specialists' for 'real-time insights' and a 'comprehensive site visit program' for training. [cite: 19 in Pricing & Value search] This hands-on, dedicated support is crucial for a complex interventional system used in high-stakes procedural environments. [cite: 19 in Pricing & Value search]
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | CARTO 3 EP Navigation System Software V8.0 (FG-5400-00 |
|---|---|---|
| Name | AVIEW LCS | CARTOu2122 3 EP Navigation System Software V8.0 (FG-5400-00 |
| Company | Coreline Soft Co. | Biosense Webster, Inc. |
| Primary Function | AI-powered solution for the detection and analysis of lung nodules, lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. | FDA-cleared, AI-powered 3D cardiac mapping and navigation system for electrophysiologists, enhancing diagnosis and treatment of heart rhythm disorders. |
| Tagline | AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment | Efficiency at Heart. Excellence at Hand. |
| Key AI Application | Automated lung nodule detection and analysis, Emphysema quantification, Coronary Artery Calcification (CAC) scoring | Machine learning for enhanced signal analysis, AI/deep-learning for automated 3D left atrial anatomy creation |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and CARTO 3 EP Navigation System Software V8.0 (FG-5400-00.